Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Tests Blood In APAC; Goes For Deeper Penetration With NAT Tests

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Novartis Diagnostics dominated a large number of Western markets with its nucleic acid testing assays for donated blood, and now the Novartis unit is aiming to mirror that success in the Asia-Pacific region by aligning with private institutions, collaborating with progressive states in countries like India and working closely with non-governmental organizations
Advertisement

Related Content

In India, Roche Diagnostics Grows At Twice The Market Rate, But Public Awareness Still Low
In India, Roche Diagnostics Grows At Twice The Market Rate, But Public Awareness Still Low
Will World's Largest HCV Population Have Access To Newest Treatments?
Will World's Largest HCV Population Have Access To Newest Treatments?
Advertisement
UsernamePublicRestriction

Register

SC078165

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel